Advertisement

Topics

Dendritic NanoTechnologies Inc Company Profile

16:11 EDT 20th September 2017 | BioPortfolio

Dendritic NanoTechnologies Inc. (DNT) is the world’s leading developer and provider of advanced dendritic polymers. DNT has breakthrough technology that provides the vehicle — the targeting and delivery mechanisms — for a vast array of diagnostics and therapeutics currently in development in the biotechnology and pharmaceutical industries.DNT is a U.S. company incorporated in 2003 and located in Mount Pleasant, Michigan on the campus of Central Michigan University (CMU). DNT is developing and commercializing dendrimers — a type of polymer. These new types of nanostructures (particles so small they allow us to build new structures, literally, atom-by-atom) hold great promise for real-world applications, such as biotechnology and pharmaceuticals. DNT's business strategies are based on a broad technology platform advanced by DNT's founder, Donald A. Tomalia, Ph.D. from his initial discovery of dendrimers in 1979.

Location

2625 Denison Drive
Mount Pleasant
Michigan
48858
United States of America

Contact

Phone: (989) 774-4199
Fax: (989) 774-2322
Email: info@dnanotech.com


News Articles [68 Associated News Articles listed on BioPortfolio]

Dendritic cells develop from specialized progenitors, research shows

Dendritic cells are gatekeepers of Immunity and are crucial for the detection and initiation of Immunity against pathogens and foreign substances. Up to now dendritic cell subtypes were thought to dev...

Immune cells derived from specialized progenitors

Dendritic cells are gatekeepers of Immunity and are crucial for the detection and initiation of Immunity against pathogens and foreign substances. Up to now dendritic cell subtypes were thought to dev...

Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival

Tavernier et al. show that loss of the protective IRE1–XBP1 stress sensor results in the death of conventional dendritic cells in the lung, whereas those in the intestine survive due to a stronger...

Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2

During gestation the developing human fetus is exposed to a diverse range of potentially immune-stimulatory molecules including semi-allogeneic antigens from maternal cells, substances from ingested a...

Dendritic cells 'divide and conquer' to elude viral infection while promoting immunity

A research team led by Jackson Laboratory (JAX) Professor Karolina Palucka, M.D., Ph.D., in collaboration with a research team at Institut Curie in France led by Dr. Nicolas Manel, have addressed a lo...

JAX researchers explore how dendritic cells promote adaptive immunity to virus

A research team led by Jackson Laboratory Professor Karolina Palucka, M.D., Ph.D., in collaboration with a research team at Institut Curie in France led by Dr. Nicolas Manel, have addressed a long-sta...

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1

Jackson and colleagues show that dendritic cells transit to the lumen of lymphatic vessels through hyaluronan-mediated interactions with the endothelial receptor LYVE-1.

PAR-1 promotes microtubule breakdown during dendrite pruning in Drosophila

Pruning of unspecific neurites is an important mechanism during neuronal morphogenesis. Drosophila sensory neurons prune their dendrites during metamorphosis. Pruning dendrites are severed in their pr...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Viroptic [Monarch Pharmaceuticals, Inc]

VIROPTIC Ophthalmic Solution, 1% Sterile(trifluridine ophthalmic solution)

Zirgan [Bausch & Lomb Incorporated]

These highlights do not include all the information needed to use ZIRGAN safely and effectively. See full prescribing information for ZIRGAN.ZIRGAN (ganciclovir ophthalmic gel) 0.15%Initial U.S. Appro...

Trifluridine [Falcon Pharmaceuticals, Ltd.]

TRIFLURIDINE OPHTHALMIC SOLUTION, 1%

Statrol®neomycin and polymyxin bsulfates ophthalmic ointment, usp [ALCON LABORATORIES, INC.]

Statrol®neomycin and polymyxin Bsulfates ophthalmic ointment, USP

Statrol®neomycin and polymyxin bsulfates ophthalmic solution, usp [Alcon]

Statrol®neomycin and polymyxin Bsulfates ophthalmic solution, USP

PubMed Articles [389 Associated PubMed Articles listed on BioPortfolio]

Emerging Trends in Micro- and Nanoscale Technologies in Medicine: From Basic Discoveries to Translation.

We discuss the state of the art and innovative micro- and nanoscale technologies that are finding niches and opening up new opportunities in medicine, particularly in diagnostic and therapeutic applic...

Drebrin and Spine Formation.

Dendritic spines are the postsynaptic receptive regions of most excitatory synapses in the central nervous system. Thus, spines are supposed to act as a fundamental unit for information processing of ...

Antigenic GM3 Lactone Mimetic Molecule Integrated Mannosylated Glycopeptide Nanofibers for the Activation and Maturation of Dendritic Cells.

The ability of dendritic cells to coordinate innate and adaptive immune responses makes them essential targets for vaccination strategies. Presentation of specific antigens by dendritic cells is requi...

Interactions with Astroglia Influence the Shape of the Developing Dendritic Arbor and Restrict Dendrite Growth Independent of Promoting Synaptic Contacts.

Astroglia play key roles in the development of neurons, ranging from regulating neuron survival to promoting synapse formation, yet basic questions remain about whether astrocytes might be involved in...

RAB15 empowers dendritic cells to drive antiviral immunity.

CD1c(+) and CD141(+) dendritic cells cooperate to sustain antiviral T cell responses.

Clinical Trials [291 Associated Clinical Trials listed on BioPortfolio]

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.

Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer

The purpose of this study is to assess the safety and activity of DC/PC3, a dendritic cell vaccine used as immunotherapy for prostate cancer. The vaccine is made with each participants' o...

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

To define the safety and efficacy of sibling-supplied, HIV antigen-pulsed dendritic cells in increasing the immune response in HIV-infected patients. Dendritic cells are a type of white b...

Alpha-Type 1 Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Dendritic cells or "DCs" are special white blood cells that stimulate the immune system. This study is being done to test the feasibility, safety and efficacy of a specific type of dendrit...

Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme

Adult patients who have surgical resection of newly diagnosed glioblastoma multiforme will be treated with radiotherapy/chemotherapy followed by dendritic cell vaccine. Chemotherapy will ...

Companies [30 Associated Companies listed on BioPortfolio]

Dendritic NanoTechnologies Inc

Dendritic NanoTechnologies Inc. (DNT) is the world’s leading developer and provider of advanced dendritic polymers. DNT has breakthrough technology that provides the vehicle — the targeting and de...

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are ba...

DCPrime

DCPrime develops off-the-shelf dendritic cell-based vaccines for a broad range of cancer types, based on its unique, proprietary technology platform, DCOne™. DCOne-based dend...

MagForce Nanotechnologies AG

MagForce Nanotechnologies AG is a world-leading company in the area of nanotechnology-based cancer treatment. Its patented Nano-Cancer® therapy enables the targeted destruction...

The Project on Emerging Nanotechnologies

More Information about "Dendritic NanoTechnologies Inc" on BioPortfolio

We have published hundreds of Dendritic NanoTechnologies Inc news stories on BioPortfolio along with dozens of Dendritic NanoTechnologies Inc Clinical Trials and PubMed Articles about Dendritic NanoTechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dendritic NanoTechnologies Inc Companies in our database. You can also find out about relevant Dendritic NanoTechnologies Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record